Patents by Inventor Yadong GE

Yadong GE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230149873
    Abstract: A method for preparing supercritical fluid by deep-sea pressure is provided and belongs to the technical field of supercritical fluid preparation. The method includes the following steps of: placing low-pressure fluid in a closed flexible container, sending the closed flexible container down to a location of a sea at a depth where a seawater pressure meets a requirement by using a powered or unpowered traction device, leaving the flexible container standing still until a volume of the flexible container does not change, wrapping the closed flexible container with a rigid pressure-bearing container, transferring the closed flexible container to the sea surface by the powered or unpowered traction device, and taking out the fluid in the flexible container as supercritical fluid. Then the supercritical fluid is produced. Therefore, the process of preparing supercritical (high pressure) liquid in deep-sea is safer and more stable than the preparation way on land.
    Type: Application
    Filed: December 14, 2021
    Publication date: May 18, 2023
    Inventors: Guanyi Chen, Junyu Tao, Yadong Ge, Beibei Yan, Yunan Sun, Zhanjun Cheng, Jian Li, Lan Mu, Yongjie Hu
  • Patent number: 11161851
    Abstract: The present invention relates to a method for preparing the compound of formula IV, compound of formula XI, and acalabrutinib, a new generation of bruton tyrosine kinase (BTK) inhibitor.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: November 2, 2021
    Assignee: Suzhou PengXu Pharmatech Co. Ltd.
    Inventors: Peng Wang, Pixu Li, Xiangyong Gu, Yadong Ge, Zhong Wang, Feng Gao, Qiangqiang Du
  • Publication number: 20200354368
    Abstract: The present invention relates to a method for preparing the compound of formula IV, compound of formula XI, and acalabrutinib, a new generation of bruton tyrosine kinase (BTK) inhibitor.
    Type: Application
    Filed: November 5, 2018
    Publication date: November 12, 2020
    Applicant: SUZHOU PENGXU PHARMATECH CO., LTD.
    Inventors: Peng WANG, Pixu LI, Xiangyong GU, Yadong GE, Zhong WANG, Feng GAO, Qiangqiang DU